Skip to main content
Log in

Antisense RNA of survivin enhances the sensitivity of pancreatic cancer cell line PANC-1 to doxorubicin

  • Published:
Chinese Journal of Cancer Research

Abstract

Objective

This paper attempts to discuss the effects of surviving antisense RNA on doxorubicin-induced apoptosis in pancreatic cancer cell line PANC-1.

Methods

A surviving antisense eukaryotic vector pcDNA3-SV Vas prepared in previous study was delivered into PANC-1 by electroperforation. Cell survival fraction and MTT assay were used to investigate the sensibility of transfected cells to doxorubicin. Apoptosis was detected by DNA gel electrophoresis.

Results

We obtained two positive cell clone PANC—1/SVVas and PANC-1/neo cells, the growth of PANC-1/SV Vas cells was significantly reduced (P<0.05). By MTT assay, the IC50 to doxorubicin of PANC-1/SV Vas, PANC-1/neo and PANC-1 cells were (0.285±0.012) μ mol/L, (1.528±0.317) μ mol/L and (1.540±0.253) μ mol/L respectively, the difference was significant by statistic analysis (P<0.01). Agarose gel electrophoresis of genomic DNA from PANC/SV Vas showed typical DNA ladder, but DNA from PANC-1/neo and PANC-1 did not.

Conclusion

Survivin antisense RNA could enhance doxorubicin-induced apoptosis in pancreatic cancer cell line PANC-1. This may lay an experimental foundation for further research of gene therapy in pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Robert AO, APaula SW, Bettina SH, et al. A novel antisense oligonucleotide targeting surviving expression induces apoptosis and sensitizes lung cancer cells to chemotherapy[J]. Cancer Res 2000; 60: 2805–9.

    Google Scholar 

  2. Marzia P, Gennaro C, Marco F, et al. Ribozyme-mediated attenuation of surviving expression sensitizes human melanoma cells to cisplatin-induced apoptosis[J]. J Clin Invest 2002; 109: 285–6.

    Article  Google Scholar 

  3. Tam I, Wang Y, Sausville DA, et al. IAP-family protein surviving inhibits caspase activity and apoptosis induced by Fas(CD95), Bax, caspase, and anticancer drugs[J]. Cancer Res 1998; 58: 5315–20.

    Google Scholar 

  4. Izant JG, Weitranb H. Inhibition of thymidine kinase gene expression by antisense RNA: A molecular approach to genetic analysis[J]. Cell 1984; 36: 1007–10.

    Article  PubMed  CAS  Google Scholar 

  5. Ambrosini G, Adida C, Altieri DC. A novel antiapoptosis gerne, surviving, expressed in cancer and lymphoma[J]. Nat Med 1997; 3: 917–21.

    Article  PubMed  CAS  Google Scholar 

  6. Adida C, Crotty PL, McGrath J, et al. developmentaly regulated expression of the novel cancer antiapotposis gene surviving in human and mouse differentiation[J]. Am J Pathol 1998; 152: 43–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shen Jing-hua  (沈敬华).

Additional information

Foundation item: This work was supported by a grant from the Natural Sciences Foundation of the Inner Mongolia Autonomous Region (No. 200308020605).

Biography: SHEN Jing-hua(1960–), female, master of medicine, associate professor, Inner Mongolia Medical College, majors in medical oncology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shen, Jh., Wang, Xj., Wang, Xm. et al. Antisense RNA of survivin enhances the sensitivity of pancreatic cancer cell line PANC-1 to doxorubicin. Chin. J. Cancer Res. 18, 138–141 (2006). https://doi.org/10.1007/s11670-006-0138-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-006-0138-2

Key words

CLC number

Navigation